Marathon Petroleum (MPC) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Marathon Petroleum (MPC) closed down 1.11% recently, underperforming the S&P 500 for the day, though it has outperformed over the past month with a 12.31% gain. Ahead of its November 4, 2025, earnings report, the company projects a 54.55% increase in upcoming quarterly EPS to $2.89, despite full-year EPS and revenue forecasts indicating declines of 20.82% and 10.99% respectively. MPC currently trades at a valuation premium with a Forward P/E of 24.23 and a PEG ratio of 3.68, both above industry averages, and holds a Zacks Rank of #3 (Hold) following a slight downward revision in recent EPS estimates.

Analysis

Marathon Petroleum (MPC) exhibits a conflicting profile of strong recent performance against a backdrop of weakening forward-looking fundamentals and a premium valuation. While the stock's 12.31% appreciation over the past month significantly outpaced both the S&P 500 and its own sector, its latest daily session saw a 1.11% decline, underperforming the broader market. The primary near-term catalyst is the upcoming earnings report, where consensus projects a robust 54.55% year-over-year increase in quarterly EPS to $2.89. However, this profitability spike is juxtaposed with an anticipated 12.88% decline in quarterly revenue. This divergence becomes more pronounced in the full-year outlook, with forecasts pointing to a 20.82% drop in earnings and an 11.0% fall in revenue. Compounding these concerns are valuation metrics; MPC's Forward P/E of 24.23 and PEG ratio of 3.68 are substantially higher than the industry averages of 17.78 and 1.51, respectively. This suggests the stock is priced richly relative to its peers and its own projected growth. The neutral Zacks Rank of #3 (Hold) and a recent 0.23% downward revision in the consensus EPS estimate further signal that analyst sentiment is cautious, reflecting the tension between near-term margin strength and a weaker top-line and full-year trajectory.

Key Decisions for Investors

• Given the stock's significant 12.31% monthly run-up and premium valuation metrics, particularly a PEG ratio of 3.68 versus the industry's 1.51, investors holding the stock may consider trimming positions to realize recent gains.
• Potential investors should exercise caution, as the projected 54.55% quarterly EPS growth is undermined by declining revenue forecasts and a weak full-year outlook, suggesting a more attractive entry point may emerge if valuation corrects.
• Closely monitor the upcoming November 4th earnings call for management's guidance on full-year performance and commentary that addresses the divergence between earnings growth and revenue decline, which will be critical to justifying the current valuation premium.